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Background: Neurosurgical operations cause unavoidable damage to healthy brain tissues. Direct surgical injury as
well as surgically induced oxidative stress contributes to the subsequent formation of brain edema. Therefore, we
tested the neuroprotective effects of hydrogen (H2) in an established surgical brain injury (SBI) model in rats.
Materials and methods: Adult male Sprague - Dawley rats (weight 300-350g) were divided into three groups to
serve as sham operated, SBI without treatment, and SBI treated with H2 (2.9%). Brain water content,
myeloperoxidase (MPO) assay, lipid peroxidation (LPO), and neurological function were measured at 24 hrs after
SBI.
Results: SBI resulted in localized brain edema (p = < 0.001). Hydrogen (2.9%) administered concurrently with
surgery significantly decreased the formation of cerebral edema (p = 0.028) and improved neurobehavioral score
(p = 0.022). However, hydrogen treatment failed to reduce oxidative stress (LPO assay) or inflammation (MPO assay)
in brain tissues.
Conclusions: Hydrogen appears to be promising as an effective, yet inexpensive way to reduce cerebral edema
caused by surgical procedures. Hydrogen has the potential to improve clinical outcome, decrease hospital stay, and
reduce overall cost to patients and the health care system.
Introduction
In 2008, close to 800,000 patients underwent neurosur-
gical procedures in the United States. This figure
encompasses emergent, life-preserving surgeries, as well
as planned procedures. Neurosurgical operations have
the potential to cause unavoidable healthy brain tissue
damage as a result through application of pressure, tis-
sue stretching, hemorrhage, and the use of electrocau-
tery [1,2]. This damage occurs despite intraoperative
adjunct treatments such as administration of steroids
and mannitol, irrespective of the procedure being
planned or emergent. Even standard microsurgical tech-
nique has the potential to cause damage to the sur-
rounding brain and lead to early complications such as
edema and local ischemia [3]. Furthermore so-called
“minimally-invasive” operations and endoscopic-assisted
procedures are not immune to damage the surrounding
structures [4]. Moreover, radiosurgery, which has the
least invasive method of addressing intracranial lesions,
has the potential to cause severe cerebral edema [5].
Some clinical-used therapeutic agents have shown to
be neuroprotective in experimental models [6].
Although pretreatment of the subjects may be an option
for planned procedures, it proves to be not useful in the
emergent setting for obvious reasons. The ideal therapy
would be to start at the time when the neurosurgical
intervention is carried out, and is completed at the time
when the intervention is completed. Furthermore, this
therapy should have a low profile with regard to toxicity,
adverse effects, drug-drug interaction, and should also
be cost-effective.
Recent data suggests that hydrogen (H2)h a sn e u r o -
protective effects in an experimental model of cerebral
ischemia [7]. Inhaled hydrogen was shown to decrease
the infarct size by reducing reactive oxygen species for-
mation. We hypothesize that hydrogen, inhaled conco-
mitantly with the neurosurgical intervention, has
potential to reduce brain edema and improve
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Materials and methods
This protocol was evaluated and approved by the Insti-
tutional Animal care and Use Committee at Loma Linda
University, Loma Linda, CA.
The SBI model
The SBI model in rodents has been described previously
[8]. Briefly, the rationale is that a controlled insult - a
partial right frontal lobectomy - mimics standard surgi-
cal procedures. By using fixed coordinates (see below),
the repeatability of this procedure is insured. By creating
a lesion close to the right primary sensory and motor
cortices, it is possible to observe impairments in neuro-
logical function. Both sensory as well as motor systems
are affected and are quantifiable with established, objec-
tive tests. Brain water content measurement after sacrifi-
cing the animal assures an objective, quantitative
method to evaluate edema formation.
Surgical Procedure
Adult male Sprague - Dawley rats (weight 300-350 g)
were used for this study. The rodent model of SBI was
used as described previously [8]. All animals were intu-
bated and subject to general anesthesia, using 3%
halothane for induction and 1% for maintenance. A
square cranial window was drilled such that the left
lower corner of the square was at the bregma. The dura
was opened and reflected to expose the underlying right
frontal lobe. Using a sharp blade, two incisions were
made along the saggital and coronal planes leading away
from the bregma to limit the partial lobectomy to 2 mm
lateral to the saggital plane and 1mm rostral to the cor-
onal plane. The depths of the resection extended to the
base of the anterior fossa. Hemostasis was achieved by
using saline irrigation, packing, and electrocautery.
Sham surgery included only craniotomy and replace-
ment of the bone flap without dural penetration. Ani-
mals were sacrificed at 24 hours. The 24 hour time
point appears to be the time of peak edema formation
in rodents, making it thus the prime target for any ther-
apy aimed at edema reduction.
All animals were intubated for sixty minutes regard-
less of the length of the operation and group. This
allows for a constant in the length of intubation and
hydrogen administration. No surgery exceeded sixty
minutes.
Treatment Groups
H2 was administered via the endotrachial tube. A tank
premixed with 2.9% hydrogen, 21% oxygen and nitrogen
balance was used for the treatment group and sham
(2.9%, Praxair, CA, USA). The control group received
21% oxygen and nitrogen balance. Treatment time con-
sisted of 60 minutes for all groups. The tubing was
checked for leaks and adequate concentrations of hydro-
gen at the endotrachial tube prior to the procedure
using a Hydrogen-meter (H2 Scan, CA, USA).
Brain Water Content
The animals were sacrificed under deep anesthesia at 24
hours after frontal lobe injury. The brains were removed
and divided into frontal ipsilateral, frontal contralateral,
parietal ipsilateral, parietal contralateral, brain stem and
cerebellum on ice. These parts were weighed immedi-
ately (wet weight) and weighed again after drying in an
oven at 105ºC for 48 hours (dry weight) as described
previously [8]. The percent of water content was calcu-
lated as [(wet weight - dry weight)/wet weight] × 100%.
The number of animals used in each group for brain
edema study was control (n = 12), sham (n = 8), hydro-
gen-treated (n = 12).
Myeloperoxidase Assay
Methodology for the myeloperoxidase (MPO) assay has
been described previously [9]. Briefly, frozen samples
(n = 18) were cut into 0.1-0.2 g pieces and homoge-
nized with Tris-HCl and Na
+ buffer. The samples were
then centrifuged at 14,000 g for 30 minutes. The
supernatants were discarded and the samples were
resuspended in 0.5%HTAB/K
+ buffer. Several cycles of
freezing in liquid nitrogen followed by sonication at
25°C were performed, before spectrophotometrical
analysis at 460 nm. The value was divided by the exact
weight of the sample and expressed in MPO activity
Unit/gram.
Lipid Peroxidation Assay
The method for Lipid Peroxidase (LPO) Assay has been
described in detail previously [10]. Briefly, animals (n =
18) were anesthetized and brain samples were collected
at 24 hours after SBI. The level of lipid peroxidation
products (malondialdehyde [MDA]) in the right cerebral
cortexes was measured using a LPO-586 kit (OxisRe-
search; Portland, OR). Right frontal cerebral cortexes
were homogenized in 20 mmol/L phosphate buffer (pH
7.4) with 0.5 M butylated hydroxytoluene in acetonitrile.
The homogenates were centrifuged at 20,800 g for 10
min at 4°C and the supernatants were collected. Protein
concentration was measured by DC protein assay (Bio-
Rad) and the samples were reacted with a chromogenic
reagent at 45°C for 60 min. After incubation, the sam-
ples were centrifuged at 20,800 g for 10 min at 4°C and
supernatants were measured at 586 nm. The level of
MDA was calculated as picomoles per milligram protein
according to the standard curve.
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We used a 21-point score adapted from the one devel-
oped for stroke by Garcia et al. [11] as presented in
Table 1. Furthermore, weu s e dt h ew i r e - h a n ga n d
beam balance tests for assessment of balance, strength,
and coordination. The wire-hang and beam balance
test were assessed based on a three point scale with
dependence on time and/or reaching the platform. 0 =
less than 15 seconds, no movement towards platform,
1 = less than 40 seconds, no movement towards plat-
form, 2 = less than or equal to half distance to plat-
form within 40 seconds, and 3 = reaching platform
within 40 seconds. Three trials were performed while
animals were receiving a five minute rest period in
between trials. The final score was the average of three
trials.
Statistical Analysis
All data were collected in SigmaPlot and analyzed with
SigmaStat (both Systat Software, Inc, San Jose, CA). The
one-way ANOVA test was used to calculate statistical
significance between samples. P value below 0.05 was
considered as statistically significant.
Results
Outcome after SBI
SBI results in localized brain edema (Figure 1A). This
simply demonstrates the validity of the model. Hydrogen
(2.9%) administered concurrently with surgery signifi-
cantly decreased the formation of cerebral edema (Figure
1B) evidenced by the decrease in brain water content.
Twenty-four hours after the operation, all animals
underwent standardized, blinded neurological evaluation.
The sensory as well as motor evaluation showed a sig-
nificant improvement in the hydrogen treatment groups
compared to the control (Figures 2A-C).
Chemical Analysis
Lipid peroxidation (LPO) assay did not show a decrease
in oxidative stress in the hydrogen group. Paradoxically,
the amount of oxidative stress increased compared to
the sham and control group (Figure 3A).
Myeloperoxidase (MPO) assay was unable to demon-
strate a significant attenuation of the inflammation asso-
ciated with SBI. There was no statistically significant
difference between treatment and control groups (Figure
3B).
Discussion
Vasogenic edema, resulting after breakdown of the
blood brain barrier, is often associated with mass lesions
and is encountered frequently clinically [12]. This hap-
pens not only during pathological processes, such as a
tumor growth [13], but also occurs in normal healthy
brain tissues caused by a neurosurgical manipulation
[2]. We have observed in this study that localized brain
edema occurred after SBI in rats, which leads to poor
neurological function, accompanied by increase of lipid
peroxidation in the injured brain tissues.
Inhaled 2.9% hydrogen during 60 minutes of surgical
procedures significantly reduced brain edema and
improved neurological function. This study provides evi-
dence that inhaled hydrogen could be an easy, eco-
nomic, convenient, and applicable approach for
anesthesiologists and neurosurgeons to reduce surgery
induced brain edema and tissue injury.
Even though we have observed positive results on the
clinical outcomes, we could not confirm the mechan-
isms of hydrogen induced neuroprotection reported by
others [7]. It has been postulated that hydrogen reacts
with reactive oxygen species causing a decreases in oxi-
dative stress at the tissue level and thus decreasing the
amount of blood brain barrier breakdown [7]. The
Table 1 The Garcia Neurological Scoring Scale
Test 3 2 1 0
I Spontaneous
activity
3-4 walls, 1-2 walls plus raise
on hindlimbs
1-2 walls Minimal movement Akinesia


















Bilateral turning >450 Bilateral turning <450 Unilateral turning No turning
VI Forelimb
walking
Brisk forward Moves toward on side Moves in circle Cannot move
forelimbs
VII Climbing Climbs to top Climbs up weak or strong but not to
top
Moves laterally or downward Weak grip and
falls off
Note: The neurological evaluation system adapted from Garcia et al. This system was applied to all groups in a blinded fashion.
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in the decreases vasogenic edema formation [14]. We
measured lipid peroxidation, the final outcome of oxida-
tive stress [15]. SBI produced localized brain edema
accompanied by an increase of lipid peroxidation in this
rat model. Inhaled hydrogen reduced formation of brain
edema, but not only did it fail to reduce, but rather it
enhanced lipid peroxidation significantly. This observa-
tion is not consistent with a previous report that hydro-
gen is a scavenger of free radicals [7]. Somehow, our
results in this study are consistent with one of our pre-
vious publications that hydrogen failed to reduce lipid
peroxidation in a neonatal hypoxia-ischemia rat pup
model [16]. Even though it is possible that hydrogen sca-
venges selectively hydroxyl radicals [7], the overall effect
of hydrogen on lipid peroxidation is either ineffective
[16] or potentiating, as observed in this study. It is not
clear whether there is an interaction between halothane
and hydrogen. However, Ohsawa et al. demonstrated H2
Figure 2 Hydrogen on neurological function.( A )N e u r o l o g i c a l
outcome scores adapted from Garcia et al. showing the difference
between hydrogen-treated animals and untreated as well as sham
animals (n = 34). The bars represent the standard error. (B) The
beam balance test, quantifying balance and coordination, showing
the difference in hydrogen-treated animals versus controls (n = 34).
The bars represent the standard error. (C) The wire hang test,
quantifying coordination and strength, demonstrating the difference
between hydrogen-treated animals and controls (n = 34). The bars
represent the standard error.
Figure 1 Hydrogen on brain water content. (A) Localized edema
formation localized in the right frontal lobe demonstrating the
efficacy of the SBI model. The right frontal lobe exhibit the highest
water content in relation to all other brain sections (n = 12). The
bars represent the standard error. (B) Percent brain edema in the
right frontal region comparing the untreated partial right frontal
lobectomy group to the hydrogen-treated partial right frontal
lobectomy group (n = 32). The bars represent the standard error.
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the existence of halothane [7]. It suggests that hydrogen-
induced neuroprotection is halothane-independent.
Because hydrogen failed to reduce lipid peroxidation,
we examined its effect on inflammation. It has been
reported that inflammation contributes to secondary
brain injury in stroke and traumatic brain injury [17],
and anti-inflammatory strategy achieved marked brain
protection in different experimental models [18]. There-
fore it is highly likely that surgical brain injury is par-
tially mediated by inflammatory responses in rats and in
mice. Similar observations of surgical induced brain
injury mediated by inflammation have been reported.
Because neural inflammation can be detected by MPO
assay [9], we measured MPO in sham, SBI, and SBI
treated with hydrogen rats. We found, however, that
MPO was not increased after surgical brain injury and
inhaled hydrogen did not increase or decrease MPO
activity.
Inhaled hydrogen gas has been proven to be safe in
humans (divers) at low concentrations [19]. Even though
pure hydrogen is safe, the threshold for combustion of
hydrogen if mixed with oxygen lies at four percent [20].
It has been shown that with 2-4% of H2 inhalation sig-
nificantly reduced infarct volume against middle cerebral
artery occlusion [7]. In our study with 2.9% and for only
one hour, we are clearly observing a phenomenon of
decreasing cerebral edema formation as well as
improved functional outcome in animals treated with
inhaled hydrogen. Therefore, hydrogen appears to be
promising as an effective, yet inexpensive way to reduce
cerebral edema. The non-toxicity of low-dose hydrogen
[3] coupled with its availability and ease of administra-
tion makes a clinical translation very simple and foresee-
able in the near future. Based on the results observed in
this study, perioperative use of hydrogen has the poten-
tial to improve clinical outcome, decrease overall health-
care cost and length of hospital stay, as well as
increased patient satisfaction. Further investigations are
necessary to elucidate the exact mechanism in which
hydrogen exerts its protecti o no nn e u r o n a lt i s s u e s .O u r
study only assessed the effects of H2 treatment acutely
following surgical-induced brain injury. Since neurosur-
gical operations have been reported to cause postopera-
tive cognitive dysfunction [21], it will be interesting to
investigate the long term effects of H2 inhalation in the
future, such as cognitive and memory functions follow-
ing SBI.
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Figure 3 Hydrogen on brain lipid peroxidation and MPO.( A )
The Lipid peroxidation (LPO) assay showing the increased oxidation
in the Hydrogen-treated group compared to sham (n = 18). The
bars represent the standard error. (B) The myeloperoxidase (MPO)
assay showing no difference in inflammation in all study groups (n
= 18). The bars represent the standard error.
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